研究・業績

2021年

  1. Itakura J, Kurosaki M, Setoyama H, Simakami T, Oza N, Korenaga M, Tanaka M, Torimura T, Sakamoto N, Enomoto N, Ueno Y, Kawada N, Kaneko S, Nishiguchi S, Chayama K, Tanaka J, Izumi N, Kanto T.
    Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis.
    J Gastroenterol. 2021 May;56(5):470-478. doi: 10.1007/s00535-021-01782-3. Epub 2021 Mar 31.

  2. Sakamoto Y, Yoshio S, Doi H, Mori T, Matsuda M, Kawai H, Shimagaki T, Yoshikawa S, Aoki Y, Osawa Y, Yoshida Y, Arai T, Itokawa N, Atsukawa M, Ito T, Honda T, Mise Y, Ono Y, Takahashi Y, Saiura A, Taketomi A, Kanto T.
    Increased Frequency of Dysfunctional Siglec-7-CD57+PD-1+ Natural Killer Cells in Patients With Non-alcoholic Fatty Liver Disease.
    Front Immunol. 2021 Feb 22;12:603133. doi: 10.3389/fimmu.2021.603133. eCollection 2021.
    内容紹介

  3. Osawa Y, Yoshio S, Aoki Y, Korenaga M, Imamura M, Oide T, Okawara M, Kawai H, Tsutsui Y, Yoshida Y, Yoshikawa S, Mori T, Yamazoe T, Kanto T.
    Blood angiopoietin-2 predicts liver angiogenesis and fibrosis in hepatitis C patients. BMC Gastroenterol. 2021 Feb 8;21(1):55. doi: 10.1186/s12876-021-01633-8.

  4. Yoshio S, Kanto T.
    Macrophages as a source of fibrosis biomarkers for non-alcoholic fatty liver disease. Immunol Med. 2021 Jan 14:1-26. doi: 10.1080/25785826.2020.1868664.

共著論文

  1. Tsuchihashi J, Koya S, Hirota K, Koga N, Narao H, Tomita M, Kawaguchi T, Hashida R, Nakano D, Tsutsumi T, Yoshio S, Matsuse H, Sanada T, Notsumata K, Torimura T.
    Effects of In-Hospital Exercise on Frailty in Patients with Hepatocellular Carcinoma. Cancers (Basel). 2021 Jan 7;13(2):194. doi: 10.3390/cancers13020194.

国立国際医療研究センター
肝炎・免疫研究センター
肝疾患研究部

〒272-8516 千葉県市川市国府台1-7-1
TEL 047-372-3501/FAX 047-375-4766